Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396915 · ClinicalTrials.gov registry record
Effects of Increased, Egg-Based Protein Intake on Muscle Composition,
A clinical trial, sponsored by Purdue University.
- Completed
- Registry status
- 22
- Enrollment target
NCT01396915: Completed study, sponsored by Purdue University.
NCT01396915 is a clinical trial that has completed, run by Purdue University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01396915 has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This study is designed to assess the effect of a diet-controlled nutrition program utilizing an egg-based higher protein diet on muscle composition and size, and indices of metabolic health and markers of systemic inflammation in older men and women who are slightly overweight.
Primary Outcome
Anticipated subject recruitment completion
Interventions
- DIETARY_SUPPLEMENT Dietary Protein Intake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-02 |
What the finished NCT01396915 record still lists
NCT01396915 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dietary Protein Intake is the first listed.
NCT01396915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01396915 about?
NCT01396915 is a clinical study titled "Effects of Increased, Egg-Based Protein Intake on Muscle Composition,". This study is designed to assess the effect of a diet-controlled nutrition program utilizing an egg-based higher protein diet on muscle composition and size, and indices of metabolic health and markers of systemic inflammation in older men and women who are slightly overweight.
What is the current status of trial NCT01396915?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-02. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01396915?
The interventions under investigation include: Dietary Protein Intake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01396915?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia